Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing norepinephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norepinephrine preparation |
Inferred relationship |
Some |
|
Accidental norepinephrine poisoning |
Causative agent (attribute) |
False |
Norepinephrine preparation |
Inferred relationship |
Some |
|
Intentional noradrenaline poisoning |
Causative agent (attribute) |
False |
Norepinephrine preparation |
Inferred relationship |
Some |
|
intoxication par la norépinéphrine d'intention indéterminée |
Causative agent (attribute) |
False |
Norepinephrine preparation |
Inferred relationship |
Some |
|
tartrate acide de norépinéphrine 2 mg/mL, ampoule de 20 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norepinephrine preparation |
Inferred relationship |
Some |
|
tartrate acide de norépinéphrine de 2 mg/mL, ampoule de 2 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norepinephrine preparation |
Inferred relationship |
Some |
|
tartrate acide de norépinéphrine 2 mg/mL, ampoule de 4 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norepinephrine preparation |
Inferred relationship |
Some |
|
Poisoning caused by levarterenol |
Causative agent (attribute) |
False |
Norepinephrine preparation |
Inferred relationship |
Some |
|
Norepinephrine 1mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Norepinephrine preparation |
Inferred relationship |
Some |
|